Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Moberg Pharma AB | 259,616 | net | 05 Jun 2025 | tx 16+292,986−33,370 |
| OncoZenge AB | -9,403 | net | 05 Mar 2021 | tx 3+15,000−24,403 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 05 Jun 2025 | GRANT_AWARD | Moberg Pharma AB | 35,851 | 8.97 SEK | |
| 25 Jun 2024 | GRANT_AWARD | Moberg Pharma AB | 23,075 | 29.21 SEK | |
| 25 Jun 2024 | SALE | Moberg Pharma AB | 13,153 | 29.09 SEK | |
| 31 Aug 2023 | PURCHASE | Moberg Pharma AB | 27,621 | 5.75 SEK | first after silence |
| 27 May 2022 | PURCHASE | Moberg Pharma AB | 76,968 | 2.30 SEK | |
| 09 Nov 2021 | PURCHASE | Moberg Pharma AB | 5,000 | 5.96 SEK | |
| 10 Nov 2021 | PURCHASE | Moberg Pharma AB | 3,000 | 5.77 SEK | |
| 11 Nov 2021 | PURCHASE | Moberg Pharma AB | 3,000 | 5.91 SEK | |
| 05 Mar 2021 | PURCHASE | OncoZenge AB | 15,000 | 10.25 SEK | |
| 02 Mar 2021 | SALE | OncoZenge AB | 9,259 | 1.20 SEK | deriv |
| 02 Mar 2021 | SALE | OncoZenge AB | 15,144 | 1.10 SEK | deriv |
| 22 Dec 2020 | PURCHASE | Moberg Pharma AB | 30,916 | 6.47 SEK | first after silence |
| 22 Jan 2021 | PURCHASE | Moberg Pharma AB | 30,916 | 6.47 SEK | |
| 13 Dec 2019 | PURCHASE | Moberg Pharma AB | 16,500 | 15.68 SEK | |
| 09 Dec 2019 | SALE | Moberg Pharma AB | 5,000 | 21.70 SEK | |
| 09 Dec 2019 | SALE | Moberg Pharma AB | 2,064 | 21.95 SEK | |
| 22 Nov 2019 | OTHER | Moberg Pharma AB | 17,064 | 46.50 SEK |
2 purchases reported after at least 12 months of silence — most recent on 31 Aug 2023.